Team
Maha Ayyoub
T2i :
Anti-tumour immunity and immunotherapy
The specificities
of our research axis
Tumour antigen-specific T cells
T cell depletion
Immune checkpoint inhibitor immunotherapy
Anti-cancer vaccines
Clinical trials
Pre-clinical orthotopic models
Genomics
Trancriptomics
Research
projects
Immune complexity of epithelial cancers
Pr Alejandra Martinez et Dr Anna Salvioni
Impact of tumour immune microenvironments on the response to immunotherapies
Christel Devaud
Targeting autophagy in cancer immunotherapy
Sylvie Giuriato
Setting up clinical trials and immune monitoring of patients treated with immunotherapy.
Clara-Maria Scarlata
Role of tumour ag-specific T cells in the clinical response to immunotherapy
Pr Maha Ayyoub
THE TEAM’S
FOCUS
Discover
Understand
Live Feed
Thrilled to announce that @Institut_cancer has awarded a 5 yr label to the COALA (Cure Oncogene Addicted Lung Adenocarcinoma) network that gathers 15 research teams in France. Looking forward to starting the program and improving patients outcome. @CHUdeToulouse @crctoncopole
Scientific production
PUBLICATIONS 2024
PUBLICATIONS 2023
PUBLICATIONS 2022
PUBLICATIONS 2021
PUBLICATIONS 2020
PUBLICATIONS 2019
LES MEMBRES DE L’ÉQUIPE
Partnerships & Funding
Centre de Recherches en Cancérologie de Toulouse (Oncopole)
Toulouse – FR
CRCT-Oncopole Follow 1,433 1,279
Compte officiel du Centre de Recherches en Cancérologie de Toulouse
🇬🇧Cytidine deaminase-dependent mitochondrial biogenesis as a potential vulnerability in pancreatic cancer cells. ImPact team @CordelierPierre article from @crctoncopole published in @CommsBio
➡️https://www.crct-inserm.fr/en/targeting-the-energy-production-process-in-pancreatic-cancer-cells-which-relies-on-an-enzyme-called-cytidine-deaminase-could-make-these-cells-more-vulnerable/
Nous contacter
05 82 74 15 75
Envie de rejoindre
L’équipe du CRCT ?